Companies / Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc.
Nasdaq: CPIXCIK 1087294NASHVILLE,, TN
Financials · FY2025
Ownership
15.0M shares outstanding · as of Aug 5, 2026
Ownership
| Insiders | 41.07% | 6,153,576 |
| Institutions | 19.04% | 2,852,657 |
| Public float | 39.89% | 5,976,874 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 10
View all →| Insider | % of shares | Shares |
|---|---|---|
A.J. KazimiCEOChairman and CEO · Director · 10% owner | 38.01% | 5,695,310 |
Krogulski KennethDirector | 2.02% | 302,338 |
Galante Joseph CDirector | 0.42% | 63,656 |
Jones JamesDirector | 0.31% | 46,863 |
Young CarolineDirector | 0.23% | 35,109 |
Brown Martin S JRDirector | 0.07% | 10,300 |
Anthony Todd M.Vice Pres Organizational Dev | — | — |
Bitterman Chris T.Vice Pres Sales & Marketing | — | — |
Hamm John M.VP Chief Financial Officer | — | — |
Herman James LVP and Chief Compliance Office | — | — |
Institutional holders 31
View all →| Holder | Value | % of shares |
|---|---|---|
| $2.21M | 3.71% | |
| $1.64M | 2.75% | |
| $1.53M | 3.14% | |
| $1.08M | 1.82% | |
| $640.2K | 1.31% | |
| $531.3K | 1.09% | |
| $511.5K | 0.86% | |
| $411.8K | 0.42% | |
| $376.3K | 0.63% | |
| $371.5K | 0.76% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Perceptive Advisors LLC 13F manager | Trim | Common Stock | $-468.4K | -144K -42.25% | 196,978 1.31% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Exit | Common Stock | $-191.6K | -48K -100.00% | 0 | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | New | Common Stock | $155.6K | +24K | 24,014 0.16% of shares | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common Stock | $71.1K | +11K +20.86% | 63,547 0.42% of shares | low |
| Q1 2026 as of | Arrowstreet Capital, Limited Partnership 13F manager | New | Common Stock | $65.8K | +20K | 20,252 0.14% of shares | low |
| Q1 2026 as of | Bank of New York Mellon Corp/The 13F manager | Trim | Common Stock | $-45.7K | -14K -19.38% | 58,458 0.39% of shares | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Trim | Common Stock | $-43.5K | -13K -54.73% | 11,085 0.07% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common Stock | $37.6K | +6K +17.24% | 39,510 0.26% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| A.J. Kazimi | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| CPIX | Common Stock | 230770109 |